Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumatriptan non-responders biomarker evaluation
NL-OMON27172Recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of sumatriptan in migraine (2 arms), sponsored by Erasmus MC. Primary endpoint: Percentage change in dermal blood flow response. Started Sep 2013; status: recruiting.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NL-OMON27172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27172.